INTRODUCTION
trometry. TsCEI potently inhibited both chymotrypsin (K i ϭ 33.4 pM) and pancreatic elastase (K i ϭ 8.32 nM). Neutrophil elastase, chymase (mouse mast cell protease-1, mMCP-1), and cathepsin G were also
The whipworm, Trichuris suis, burrows into the mucosal inhibited by TsCEI, whereas trypsin, thrombin, and factor Xa were lining of the cecum and colon of its swine host and stimulates not. The cDNA-derived amino acid sequence of the mature TsCEI a stereotypical host response to gastrointestinal parasites that consisted of 58 residues including 9 cysteine residues with a molecular is characterized by mucosal mast cell hyperplasia, eosinomass of 6.196 kDa. TsCEI displayed 48% sequence identity to a previously characterized trypsin/chymotrypsin inhibitor of T. suis, TsTCI. philia, and elevated levels of reaginic antibodies (Urban et TsCEI showed 36% sequence identity to a protease inhibitor from the al., 1998). Mast cells release an array of potent chemical hemolymph of the honeybee Apis mellifera. Sequence similarity was mediators including serine proteases (Schwartz and Austen, also detected with the trypsin/thrombin inhibitor of the European frog 1984). In particular, intestinal nematode infections upreguBombina bombina, the elastase isoinhibitors of the nematode Anisakis late the secretion of the serine protease chymase, a chymosimplex, and the chymotrypsin/elastase and trypsin inhibitors of the trypsin-like protease predominantly expressed in intestinal nematode Ascaris suum. The inhibitors of T. suis, an intestinal parasite mucosal mast cells (Wastling et al., 1997) and implicated of swine, may function as components of a parasite defense mechanism as a central modulator of inflammation through its ability by modulating intestinal mucosal mast cell-associated, protease-mediated, host immune responses.
to directly activate interleukin-1␤ (Mitzutani et al., 1991) , Index Descriptors and Abbreviations: chymotrypsin (EC3.4.21.1) enhance epithelial cell permeability (Scudamore, 1998) , and inhibitor; elastase (EC3.4.21.36) inhibitor; chymase inhibitor; cathepsin stimulate inflammatory cell recruitment (Walls et al., 1993;  G inhibitor; nematode; in vitro cultivation; excretory/secretory prod- He and Walls, 1998) . Cathepsin G, a chymotrypsin-like seructs; Apis mellifera; honeybee; TsCEI, Trichuris suis chymotrypsin/ ine protease, and the serine protease elastase are released elastase inhibitor; TsTCI, T. suis trypsin/chymotrypsin inhibitor; AmCI, by activated neutrophils and also function as modulators of A. mellifera cathepsin G/chymotrypsin inhibitor; BSTI, Bombina bomthe inflammatory process.
bina skin trypsin/thrombin inhibitor ATI, Ascaris suum trypsin inhibiBecause proteases play critical roles in a variety of imtor; C/E-1, A. suum chymotrypsin/elastase inhibitor; AX-SPI-1,2,3, Anisakis simplex elastase isoinhibitors; pNA, paranitroanilide; TCA, mune cell processes, protease inhibitors have the potential 0014-4894/00 was added slowly to the T. suis soluble extract while stirring to a final to modulate these responses. Recently, we reported the secreconcentration of 2.5%. This solution was left at room temperature for tion of a T. suis inhibitor active against the serine proteases 30 min and then centrifuged at 17,300g for 10 min. The supernatant trypsin and chymotrypsin and purified a 6.7-kDa trypsin/ (TCA-soluble fraction) was dialyzed extensively with multiple changes chymotrypsin-specific peptide inhibitor, TsTCI (Rhoads et of 50 mM Tris buffer, pH 7.6. al., 2000) . The present study describes the purification and Elastase-agarose affinity chromatography. Elastase (porcine pancreas) was covalently coupled to AminoLink Plus Coupling Gel (4% characterization of a chymotrypsin/elastase-specific pepbeaded agarose, Pierce, Rockford, IL) according to manufacturer's tide inhibitor.
instructions. Briefly, 4 ml of elastase (2ϫ crystallized aqueous suspension, Sigma) dissolved in coupling buffer (0.1 M sodium phosphate, 0.15 M NaCl, pH 7.2) at a concentration of 1.5 mg/ml was incubated overnight with the gel matrix. Following immobilization, the gel was equilibrated with 50 mM Tris buffer, pH 7.6, containing 0.3 M NaCl MATERIALS AND METHODS and 10 mM CaCl 2 . The dialyzed T. suis TCA-soluble fraction (routinely 15-20 mg) was loaded onto the column, the flow rate was stopped, and the sample was allowed to incubate with the elastase-agarose for approximately 10 min. The column was then eluted with equilibration Parasites. Adult male and female T. suis were removed with forbuffer and fractions were monitored at 280 nm. When the absorbance ceps from the mucosal surface of the cecum and colon of infected returned to baseline, bound proteins were eluted with 0.01 M HCl; pigs. Parasites were rinsed consecutively with 0.85% NaCl and sterile 0.5-ml fractions were collected and assayed for inhibitor activity. Active Hanks' balanced salt solution (HBSS) and then incubated at 37ЊC for fractions were combined and lyophilized. 1 h in sterile RPMI 1640 medium containing 500 units ml Ϫ1 penicillin, Reverse-phase HPLC. The lyophilized sample from the affinity 0.5 g ml Ϫ1 streptomycin, 1.25 g ml Ϫ1 fungizone, and 350 g ml
Ϫ1
column was resuspended in 0.1% trifluoroacetic acid (TFA) and sepachloramphenicol. After a final rinse with HBSS to remove antibiotics, rated on a Jupiter C-18, 5-m, 250 ϫ 4.6-mm steel column. The mobile parasites were either homogenized or cultured in vitro as described phases consisted of A (0.1% aqueous TFA) and B (0.13% TFA in 70% (Rhoads et al., 2000) . Protein concentrations of the homogenates elasaqueous acetonitrile). The sample (100 l) was applied and eluted at tase and culture fluids were estimated by the spectrophotometric nucleic a flow rate of 1 ml/min with 85% A for 5 min, followed by a linear acid/protein analysis program (Warburg-Christian) provided with the gradient from 85% A to 100% B in 30 min; eluent was monitored at Beckman 640 spectrophotometer. 214 nm. Fractions were assayed for elastase (bovine pancreas) inhibitor Inhibitor assays. Inhibitor activity was assayed in 96-well plates activity, active fractions were pooled and rotary evaporated, and the by the inhibition of hydrolysis of synthetic peptide-paranitroanilide resulting sample was reconstituted in water. The peptide concentration (pNA) substrates by their respective proteases. The assay consisted of was estimated by absorbance at 205 nm (Stoschek, 1990) , and the 2.0 nM protease (except for factor Xa at 0.5 nM, human neutrophil specificity of the purified inhibitor was determined with chymotrypsin, elastase at 17 nM, cathepsin G at 220 nM, and chymase at 160 nM), neutrophil elastase, chymase, cathepsin G, trypsin, thrombin, and factor 50 mM Tris/HCl buffer, pH 7.5, containing 0.15 M NaCl and 0.1% Xa. The purified inhibitor was termed TsCEI. bovine serum albumin (BSA) and a 10-l aliquot of T. suis samples Apparent dissociation constants. The apparent equilibrium dissoci-(extract, culture fluids, column fractions, or purified peptide). Followation inhibitory constant (K i ) was determined for TsCEI with elastase ing a 30-min incubation, substrate (0.25 mM, except for elastase, (bovine pancreas) and chymotrypsin. Using the described assay, ratios cathepsin G, and chymase substrates at 1.0 mM) was added and the of inhibited velocity (V i ) to the uninhibited velocity (V 0 ) were plotted residual activity (mOD/min) was determined at 405 nm on a Vmax against the concentration of TsTCI as determined by quantitative amino microplate kinetic reader (Molecular Devices). The total volume of acid analysis. Data were fitted to an equation for tight-binding inhibitors the assay was 200 l. Chymotrypsin (TLCK-treated, Sigma) was (Bieth, 1974) and the K i values were determined.
Laser desorption mass spectrometry (LDMS). The molecular mass sine-pNA (Chromogenix S-2586, Diapharma, West Chester, OH); elasof TsCEI was determined by matrix-assisted laser desorption mass tase (bovine pancreas, Calbiochem, La Jolla, CA) was assayed with spectrometry. The peptide was mixed with saturated ␣-cyano-4-Boc-alanyl-alanyl-prolyl-alanine-pNA (Calbiochem); elastase (huhydroxycinnamic acid matrix solution and pulsed with a nitrogen laser man neutrophil, Calbiochem) was assayed with MeOSuc-ala-ala-(337 nm) at 20,000 V. pro-val-pNA (Calbiochem); trypsin (bovine pancreas, TPCK-treated,
Amino terminal and internal sequence analysis. Following Edman Sigma) was assayed with N-benzoyl-L-isoleucyl-L-glutamylglycyl-L-
degradation, the N-terminal sequence of TsCEI was determined on an arginine-pNA (Chromogenix S-2222, Diapharma); cathepsin G (CalbiApplied Biosystems Procise liquid-pulse protein sequenator. Internal ochem) and mMCP-1 (mouse mast cell protease-1, a chymase, kindly sequences were determined by subjecting TsCEI to Lys C protease supplied by Dr. Hugh Miller, The University of Edinburgh, Scotland) digestion (2 to 4 pmol Lys C, 100 mM Tris, pH 8.8, 2 M urea, 2.2 were assayed with Suc-ala-ala-pro-phe-pNA (Calbiochem); thrommM DTT, and 5 mM iodoacetamide) at 37ЊC for 24 h. The peptide bin (bovine plasma, Sigma) was assayed with H-D-phenylalanyl-Ldigest was fractionated by HPLC and selected peaks were subjected to pipecolyl-L-arginine-pNA (Chromogenix S-2238, Diapharma); and amino acid sequencing as described above. Peaks chosen for sequencing factor Xa (bovine plasma, Diapharma) was assayed with N-␣-benzylwere also analyzed by LDMS to confirm mass estimations.
(Chromogenix Isolation of mRNA and cDNA cloning. Total RNA was extracted S-2765, Diapharma).
Trichloroacetic acid (TCA) precipitation. Fifty percent (w/v) TCA from adult T. suis by the method of Zarlenga and Gamble (1987). First strand cDNA was generated by RT-PCR using 20 g of total RNA and 50 M oligo(dT) 16 as previously described (Lu et al., 1998) . The original primer sequences, designed from the amino acid sequence data obtained as described above, were degenerate with inosine used as the third base in each codon. Amplification of inhibitor-specific cDNA by PCR was accomplished using the first strand cDNA as a template and oligonucleotide primers based upon the exact sequence of the molecule. Each primer (Table I) contained a HindIII or EcoRI restriction site at the 5Ј end to allow subcloning in a known orientation for double-stranded DNA sequencing. Three additional bases (ACA) or a GCCG clamp was added to ensure polymerization through the restriction sites. Amplification of the 5Ј end of the inhibitor cDNA was accomplished using the modified conserved nematode 22-bp splice leader (SL-1) as the sense primer (Blaxter et al., 1994) and antisense primer based upon the peptide sequence ACTMQC. The 3Ј end of the cDNA was confirmed using oligonucleotides based upon the peptide sequence EQYTSC as the sense primer and oligo(dT) 16 as the antisense primer. The PCR contained 200 pM of each primer, 5 units of AmpliTaq DNA polymerase, and 200 M dNTP (Gene Amp Kit, Perkin-Elmer, Branchburg, NJ). The reaction mixture was heated to 94ЊC for 5 min, FIG. 1. Concentration-dependent inhibition of elastase by T. suis followed by 40 cycles of 94ЊC for 30 s, 63ЊC for 1 min, and 72ЊC for soluble extract and culture fluids. The relationship of the ratio of 45 s. The PCR products were separated on 1.5% agarose gels (FMC inhibited enzyme velocity (V i ) to uninhibited velocity (V 0 ) and the Bioproducts, Rockland, ME), isolated using glass milk (USBioclean micrograms of protein of T. suis extract (solid squares) and culture MP Kit, USB, Cleveland, OH), cloned into the pBluescript plasmid fluids (solid circles) is shown. The data were fitted to a polynomial vector (Stratagene), and sequenced by the dideoxy chain-terminator equation and the micrograms of T. suis extract and culture fluids at method (T7 Sequenase v.2.0 Kit, Cleveland, OH). The full-length 50% enzyme inhibition were determined; inhibitor units are shown in cDNA sequence was obtained by PCR using the modified SL-1 sethe inset. quence as the sense primer and antisense primers derived from sequence information determined above from regions near the poly(A)tail. PCR reaction conditions, cloning, and sequencing were as described.
Following TCA precipitation of the T. suis soluble extract, the elastase inhibitor remained in solution. The elastase inhibitor present in the TCA-soluble fraction bound to the RESULTS elastase-agarose column (little or no activity was present in the unbound fraction) and was eluted with 0.01 M HCl; this HCl-eluted fraction also inhibited chymotrypsin. ReElastase inhibitor activity was present in T. suis soluble verse-phase HPLC of the elastase-agarose-bound fraction extract and excretory-secretory products (Fig. 1) ; elastase resulted in one major protein peak (elution time of 22 min). was inhibited in a concentration-dependent manner. The ex- (Fig. 2) ; this protein peak coincided with peaks of both tract contained 2.0 units and the culture fluids 0.28 units of elastase and chymotrypsin inhibition. Analysis of this peak elastase inhibitor activity (a unit is defined as the micrograms by laser desorption mass spectrometry identified one compoof T. suis protein required to inhibit elastase activity by 50%), nent with the molecular mass estimated at 6.437 kDa (Fig.  indicating an enrichment of the inhibitor in culture fluids.
3). The purified peptide was termed TsCEI. The T. suis purified peptide inhibited chymotrypsin with a K i estimated at 33.4 pM and pancreatic elastase with a K i estimated at 8.32 nM (Fig. 4) . Partially purified TsCEI signed from these sequences were used for PCR cloning of amino acids and a 5Ј untranslated region of 63 nucleotides that included the modified SL-1 sequence at the 5Ј terminal end. The initiator codon was flanked by sequences conforming to the Kozak translation initiation prediction (Kozak, degradation. The mature polypeptide consisted of 58 amino acids with a calculated molecular weight of 6.196 kDa. 1986). The 5Ј end contained a putative signal sequence of 15 amino acid residues that was adjacent to a potential signal TsCEI showed 48% sequence identity to a previously characterized trypsin/chymotrypsin inhibitor of T. suis, sequence cleavage site (denoted by the forward slash) (Von Heijne, 1986 ) between residues Ϫ1 and ϩ1, which gave an termed TsTCI (Rhoads et al., 2000) (Fig. 7) . The TsCEI sequence was screened against all nonredundant protein seamino-terminal glutamic acid and an N-terminal 25-residue sequence identical to that determined by automated Edman quence databases maintained by the National Center for
FIG. 6.
Nucleotide sequence and deduced amino acid sequence of TsCEI precursor. The beginning of the mature protein (end of the signal peptide) is marked by a forward slash. Underlined sequences are sense primers used to discern the 5Ј end; double underlined sequences are antisense primers used to discern the 3Ј end of the molecule. Single asterisk denotes the putative initiator methionine codon (Kozak, 1986) ; double asterisk denotes the stop codon. There is a 5Ј untranslated region (63 nucleotides) that includes the 22-bp SL-1 primer sequence.
Biotechnology Information using Gapped BLAST 2.0. DISCUSSION TsCEI showed 36% sequence identity with an inhibitor from the hemolymph of the honeybee A. mellifera (SWISS-PROT locus 4699856) (Bania et al., 1999) 
with the introduction
Trichuris suis adult parasites express two distinct, lowmolecular-weight, serine protease inhibitors; these inhibitors of a 13-residue gap in the A. mellifera sequence (Fig. 7) . Sequence similarity was also detected with the trypsin inhibiare released by worms maintained in vitro. One of the inhibitors, TsTCI, was purified and characterized in a previous tor of the European frog Bombina bombina and the elastase isoinhibitors (AX-SPI-1-3) and the chymotrypsin/elastase study (Rhoads et al., 1999) . This 6.7-kDa protein inhibited trypsin (K i ϭ 3.1 nM) and chymotrypsin (K i ϭ 24.5 nM) (C/E-1) and trypsin (ATI) inhibitors of the nematodes Anisakis simplex and Ascaris suum, respectively, and again idenand contained a region (46 amino acids) with 36% sequence identity to the honeybee A. mellifera inhibitor AmCI; no tity with the TsCEI sequence was maximized by the addition of a 12-to 14-residue gap in the sequences of these inhibitors significant sequence identity was detected between TsTCI and any other previously identified serine protease inhibitors. (Fig. 7) . In addition, the 11-residue sequence CTMQC-VPGCFC exhibited similarity to sequences of the inhibitors In the present study, a 6.2-kDa protease inhibitor, TsCEI, was purified. The enzyme specificity of TsCEI was distinct of A. mellifera, B. bombina, A. simplex, and A. suum that contain the residues that interact with the catalytic site of from that of TsTCI, inhibiting both chymotrypsin (K i ϭ 33.4 pM) and pancreatic elastase (K i ϭ 8.32 nM); neutrophil their inhibited enzymes (Fig. 8) . These similarities include the positions of four cysteine residues, two of which form elastase, cathepsin G, and chymase were also inhibited. TsCEI and TsTCI showed 48% sequence identity to each the boundaries of the reactive site (Grasberger et al., 1994; Hawley et al., 1994; Huang et al., 1994) . By analogy to the other. TsCEI displayed 36% sequence identity to the honeybee inhibitor. In contrast to TsTCI, sequence similarity was reported reactive sites of the A. mellifera (Bania et al., 1999) and A. suum (Peanasky et al., 1987) inhibitors, the sequence displayed between TsCEI and the serine protease inhibitors of the parasitic nematodes A. simplex and A. suum, as well CTMQC of TsCEI is suggested as its reactive site and is identical to that of A. mellifera. The suggested reactive site as a protease inhibitor from the skin secretions of the European frog B. bombina (Mignogna et al., 1996) . The A. suum of TsTCI was CTRQC.
inhibitors (five chymotrypsin/elastase and three trypsin isoinhibitors) (Grasberger et al., 1994; Huang et al., 1994) , the A. simplex inhibitors (three elastase isoinhibitors) (Lu et al., 1998) , the inhibitor from the frog B. bombina (Mignogna et al., 1996) , and the inhibitor from the honeybee A. mellifera (Bania et al., 1999) appear to belong to a novel family of protease inhibitors, having no sequence identity with the other well-characterized serine protease inhibitor families. The inhibitors of this restricted family are characterized as small proteins (60-65 residues) containing five disulfide bonds (formed by 10 cysteine residues present in a distinct pattern), two of which form the boundaries of the reactive site (at the P 3 and P 2 positions) (Huang et. al., 1994; Grasberger et al., 1994) (Figs. 7 and 8) . The complete sequence of TsCEI consisted of 58 residues with 9 cysteine residues; TsTCI consisted of 61 residues with 8 cysteine residues. There was no pattern in the location of the cysteine residues between TsCEI and TsTCI; neither inhibitor contained the distinctive cysteine residue pattern associated with the Ascaris inhibitor family (Fig. 7) . Furthermore, the position of the reactive site residues of TsCEI and TsTCI was not similar to that of the members of this family. Yet, TsCEI and TsTCI contained an 11-residue region that displayed similarities with the regions that contain the reactive sites of the Ascaris family of inhibitors (Fig. 8) . TsCEI and TsTCI thus appear to be only distantly related to the Ascaris family of inhibitors.
The release in vitro of serine protease inhibitors by T. suis suggests that the targets for these inhibitors may be host proteases rather than endogenous parasite proteases. This is supported by the fact that both metallo- (Hill et al., 1993) and cysteine (Hill and Sakanari, 1997) proteases, but no serine proteases have been detected in T. suis. The target host proteases for the T. suis inhibitors have yet to be identified. The ability of TsCEI to inhibit neutrophil elastase and cathepsin G, which are released by activated neutrophils and macrophages, as well as the chymase mMCP-1, which is released by activated mast cells, suggests that T. suis might utilize the secreted protease inhibitors to evade host attack. The mast cell-derived proteases, consisting of both tryptases and chymases, exist in multiple forms (Reynolds et al., 1990; Stevens et al., 1999) and are expressed in a cell-and/or tissue-specific fashion (Stevens et al., 1994) , suggesting highly specialized functions (Hunt and Stevens, 1995) that have yet to be fully elucidated. Significantly, mast cells appear to play a critical role in the expulsion of parasites from the gastrointestinal tract and thus are an important component in the host defense against parasitic infections (Miller, 1984 (Miller, , 1996 . A mechanism that interferes with mast cell mediators could significantly contribute to parasite survival in the host.
FIG. 7.
Comparison of the amino acid sequence of TsCEI with TsTCI and with serine protease inhibitors of the Ascaris family. TsTCI, T. suis trypsin/chymotrypsin inhibitor; TsCEI, T. suis chymotrypsin/elastase inhibitor; AmCI, A. mellifera cathepsin G/chymotrypsin inhibitor; ATI, A. suum trypsin inhibitor; C/E-1, A. suum chymotrypsin/ elastase inhibitor; AX-SPI, A. simplex elastase isoinhibitor 1; BSTI, B. bombina skin trypsin/thrombin inhibitor. Gaps (-) were introduced to improve alignments. Identical amino acid residues are boxed; identical cysteine residues are boxed and shaded.
FIG. 8.
Comparison of amino acid sequences of reactive site regions of protease inhibitors from T. suis, A. mellifera, B. bombina, A. simplex, and A. suis. TsCEI, T. suis chymotrypsin/elastase inhibitor; TsTCI, T. suis trypsin/chymotrypsin inhibitor; AmCI, A. mellifera cathepsin G/ chymotrypsin inhibitor; BSTI, B. bombina skin trypsin/thrombin inhibitor; AX-SPI-1,2,3, A. simplex elastase isoinhibitors; C/E-1, A. suum chymotrypsin/elastase inhibitor; ATI, A. suum trypsin inhibitor. Bold letters indicate the reactive site residues. The residues around the reactive site peptide bond of the inhibitor that combine with the catalytic site of the enzyme in a substrate-like manner are designated P 3 to PЈ 2 . The peptide bond is between residues P 1 and PЈ 1 . P 1 -PЈ 1 residues were determined for AmCI and ATI by partial proteolytic cleavage at the reactive site by the cognate protease (Bania et al., 1999; Peanasky et al., 1987) . Gaps were introduced to emphasize alignment of the cysteine residues (marked Ȋ).
The ability of protease inhibitors to function as effector Macen et al., 1993) . Viral serine protease inhibitors were molecules of immunomodulation is demonstrated by the shown to contribute significantly to viral pathogenesis by regulatory role of endogenous ␣ 1 -antichymotrypsin that interacting with host cellular components involved in the tightly controls the inflammatory process of mammals by regulation of inflammation; specifically, a viral inhibitor was inactivating the proteolytic activity of chymase and cathepshown to prevent the activation of interleukin-1␤, a critically sin G (Laine et al., 1982) . In addition, ␣ 1 -antichymotrypsin important cytokine mediator of inflammatory responses displays potent antiinflammatory properties both in vitro (Ray et al., 1992) . (Carney et al., 1998) and in vivo (Murohara et al., 1995;  The severe clinical aspects of T. suis infections such as Scalia et al., 1995; Hook et al., 1995) . Another serine protemucohemorrhagic enteritis have been associated with wormase inhibitor shown to affect mammalian immune system induced suppression of mucosal immunity to intestinal tract mediators is the Bowman-Birk inhibitor (BBI) isolated from resident bacteria (Mansfield and Urban, 1996) . Concurrent soybeans and other legumes. BBI has been shown to have infections with T. suis were shown to enhance the ability of potent anticarcinogen and antiinflammatory activities in a opportunistic bacteria to multiply and cause disease and number of in vivo and in vitro model systems (review, Kenpathology; pathologic changes in the colon were noted both nedy, 1998); these biological activities have been linked to at sites of worm attachment and at distant sites. This generalthe chymotrypsin inhibitory activity of BBI. BBI has been ized colon pathology can be explained by the strong and shown to directly inhibit a number of modulators of the polarized type 2 immune response that is evoked by T. inflammatory process including cathepsin G and chymase suis and other gastrointestinal parasites, restricting immune (Larionova et al., 1994; Ware et al., 1997) . In addition, BBI flexibility and thus allowing exploitation by opportunistic prevented both the influx of PMN leukocytes into regions infections (Urban et al., 1998) . Additionally, the localized of inflammation as well as their production of active oxygen modulation of host immune effector systems by the T. suisspecies (Frenkel et al., 1987) .
released inhibitors could also contribute to increased bacteSerine protease inhibitor-mediated modulation of host imrial multiplication and pathology. mune effector systems is a strategy used by viruses to inhibit host inflammatory responses to infection (Ray et al., 1992;  In summary, T. suis may synthesize and release multiple 
